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Abstract
Background: Hyperuricemia is associated with multiple diseases, including gout, cardiovascular disease, and renal
disease. Serum urate is highly heritable, yet association studies of single nucleotide polymorphisms (SNPs) and serum
uric acid explain a small fraction of the heritability. Whether copy number polymorphisms (CNPs) contribute to uric
acid levels is unknown.
Results: We assessed copy number on a genome-wide scale among 8,411 individuals of European ancestry (EA) who
participated in the Atherosclerosis Risk in Communities (ARIC) study. CNPs upstream of the urate transporter SLC2A9
on chromosome 4p16.1 are associated with uric acid (χ22df = 3545, p = 3.19 × 10−23). Effect sizes, expressed as the
percentage change in uric acid per deleted copy, are most pronounced among women (3.974.935.87 [2.55097.5
denoting percentiles], p = 4.57 × 10−23) and independent of previously reported SNPs in SLC2A9 as assessed by SNP
and CNP regression models and the phasing SNP and CNP haplotypes (χ22 df = 3190, p = 7.23 × 10−08). Our finding
is replicated in the Framingham Heart Study (FHS), where the effect size estimated from 4,089 women is comparable
to ARIC in direction and magnitude (1.414.707.88, p = 5.46 × 10−03).
Conclusions: This is the first study to characterize CNPs in ARIC and the first genome-wide analysis of CNPs and uric
acid. Our findings suggests a novel, non-coding regulatory mechanism for SLC2A9-mediated modulation of serum
uric acid, and detail a bioinformatic approach for assessing the contribution of CNPs to heritable traits in large
population-based studies where technical sources of variation are substantial.
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Background
Serum uric acid levels are highly heritable and associated
with several diseases, including gout, hypertension, and
cardiovascular disease [1-4]. Genome-wide association
studies have identified several single nucleotide polymor-
phisms (SNPs) that are strongly associated with uric acid
levels [5-10], but a large proportion of the heritability of
uric acid is unexplained by common SNPs. While varia-
tion of DNA copy number has been implicated in many
heritable diseases, there has been no association studies of
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copy number polymorphisms (CNPs) and serum uric acid
levels on a genome-wide level.
High-throughput platforms used to genotype SNPs are
useful for copy number estimation, though additional
steps are required to reduce technical artifacts that are
prevalent in studies of copy number. Estimates of the rel-
ative copy number (log R ratios) and B allele frequencies
measured at each marker on the array are mutually infor-
mative for the latent copy number [11]. Various hidden
Markov model (HMM) implementations integrate the log
R ratios and B allele frequencies to infer copy number
[12-19]. Copy number estimation is challenging, in part,
due to technical artifacts that contribute to false pos-
itives. Among the most common artifacts are genomic
waves [20,21], an autocorrelation of the marker-level esti-
mates when plotted against physical position, and batch
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effects, differences between groups of samples arising from
technical sources of variation such as sample preparation,
reagents, and laboratory personnel [22-24]. Approaches
to reduce wave and batch artifacts include models for
adjusting log R ratios by the GC composition of the
local sequence as in [21] and surrogates of batch such as
chemistry plate in association models when confounding
between batch and phenotype is incomplete.
Here, we implement a HMM to infer integer copy num-
ber from B allele frequencies and wave-corrected log R
ratios obtained from 8,411 ARIC participants of European
ancestry assayed on Affymetrix 6.0 arrays. We evaluate
the association between CNPs and uric acid concentra-
tions through mixed effects regression models that adjust
for available clinical risk factors as well as technical covari-
ates such as chemistry plate and study center. For loci
reaching genome-wide significance, we replicate our find-
ings in the Framingham Heart Study (FHS). In addition,
we assess whether statistically significant associations
among EA participants persist in a smaller cohort of 3,392
African Americans in ARIC. Finally, we establish the inde-
pendence of the relationship between copy number and
uric acid concentrations from genome-wide significant
SNP associations among ARIC EA participants.
Results and discussion
Among 8,411 ARIC samples of European ancestry pass-
ing SNP and copy number metrics for quality control (see
Methods), 47 percent are male and the mean BMI, uric
acid concentration, and age are 27 kg/m2, 5.9 mg/dL, and 54
years, respectively.
Copy number estimates 0-4 were obtained from aHMM
[14]. In this population, the median number of deletions
and duplications is 55, and the median cumulative num-
ber of bases spanned by copy number variants (CNVs)
in autosomal chromosomes is 3, 530 kb (Additional file 1:
Figure S1 and Table S1). The number of CNVs estimated
for an individual is dependent on array quality and is
associated with batch (chemistry plate). In particular, the
detection of small CNVs (< 25 kb) requires high quality
arrays, whereas identification of large CNVs (> 200 kb)
is robust to array quality and batch (Additional file 1:
Figure S2). From the distribution of CNV breakpoints
across all EA subjects, we identified 12,397 disjoint (non-
overlapping) genomic intervals for which copy number
is unambiguous and at least 1 percent of ARIC partici-
pants have a duplication or deletion (see Methods). These
genomic intervals capture 317 non-contiguous loci con-
stituting the CNPs ascertained by the HMM among EA
ARIC participants, and nearly all span known regions
of copy number variation reported in the Database of
Genomic Variants [25].
Prior to our assessment of CNPs as potential risk factors
for hyperuricemia, we removed seasonal trends of uric
acid concentrations using a lowess smoother with span 110
fit to women and men independently. Our baseline mixed
effects model for seasonally adjusted log uric acid con-
centrations includes fixed effects for study center, age, log
BMI, gender, and the interaction of age and log BMI with
gender, as well as a random effect for chemistry plate.
For each disjoint interval, we extended the baseline
model for uric acid with copy number (0-4) mod-
eled as a continuous covariate. A Manhattan plot of
the − log10 p-value revealed a cluster of statistically
significant associations on chromosome 4 (Additional
file 1: Figure S3, A). The statistically significant coef-
ficients are derived from two non-overlapping CNPs
with NCBI36 build coordinates 9,832,502–9,844,354 bp
(CNP-9Mb) and 10,002,240–10,009,754 bp (CNP-10Mb;
Additional file 1: Figure S3, B). Together, the two CNPs
span 19.368 kb, are interrogated by 49 nonpolymorphic
markers and 1 SNP, overlap common deletions previously
identified in HapMap Phase 1 [26], and are upstream of
the SLC2A9 gene that is transcribed in the reverse direc-
tion. With the exception of the chromosome 4 locus,
the distribution of p-values is approximately uniform
(Additional file 1: Figure S4).
The marginal distribution of the average log R ratios
at CNP-10Mb and CNP-9Mb can be approximated by a
mixture of normal distributions, where the components
of the mixture are induced by differences in the latent
copy number (Figure 1A and 1C). Our approximation to
the posterior is derived from a Gibbs’ sampler [27,28],
an approach conceptually similar to the Bayesian mixture
model described in [29] and extending some of the origi-
nally proposed heuristics using mixture models for CNPs
[30]. A scatterplot of the average log R ratios at CNP-9Mb
and CNP-10Mb provides a non-discrete visualization of
their joint distribution (Figure 1B). Assuming the mixture
components correspond to latent copy numbers 0, 1, and
2, the integer copy number for each sample is inferred
from the component with highest posterior probability.
The copy number estimates from the mixture model are
further corroborated by the genotype clusters for SNP
rs4607209 in the CNP-10Mb locus (Figure 1D). For exam-
ple, samples belonging to the second mixture component
(copy number 1) populate the ‘A’ and ‘B’ genotype clusters
at SNP rs4607209 (green). Hereafter, regression mod-
els for uric acid utilize the maximum a posteriori copy
number estimates from the Bayesian mixture model.
Copy number estimates at the CNP-9Mb and CNP-
10Mb loci have a Spearman correlation coefficient of
-0.82. Homozygous deletions are common at each locus
(46% of subjects at the CNP-9Mb locus and 6% of sub-
jects at the CNP-10Mb locus), yet none of the subjects
have a homozygous deletion at both loci (233 expected
by chance). Evaluated in separate regression models, each
deleted copy at CNP-9Mb and CNP-10Mb is associated

























































Figure 1 Low-level data and posterior summaries from a Bayesian finite mixture model supporting copy number alterations. (A) A
histogram of the average log R ratios at CNP-10Mb (gray). The posterior distribution approximated by the Gibbs sampler is indicated by the black
lines overlaying the histogram. (B) The average log R ratios at the CNP-9Mb and CNP-10Mb chromosome 4 loci. (C) Same as (A) for the CNP-9Mb
locus. (D) The log-transformed intensities for alleles A and B allele at a SNP in the CNP-10Mb locus. The genotype clusters are consistent with the
copy number estimates from the mixture model.
with a 1.171.501.82 percentage decrease (p = 5.43× 10−20)
and a 1.832.633.42 percentage increase (p = 1.54 × 10−10)
in uric acid concentrations, respectively (Figure 2). While
the regression coefficients at CNP-9Mb and CNP-10Mb
are opposite in sign, the data is consistent with a dose
response to copy number at only one CNP and an oppos-
ing sign for the tagging CNP attributable to its strong link-
age disequilibrium. At each locus, the interaction of copy
number and gender is statistically significant with more
pronounced slopes observed among women. For example,
each deleted copy at the CNP-10Mb CNP among women
is associated with a 3.974.935.87 (p = 4.57×10−23) percent-
age increase of uric acid concentrations, whereas among
men each deleted copy is associated with a 0.311.362.39 (p =
0.001) percentage increase in uric acid concentrations.
To evaluate whether CNPs at the chromosome 4 loci
are associated with uric acid in an independently sam-
pled EA population for which uric acid measurements
are available, we pursued replication in FHS. Because
access to the intensity-level data in FHS was not avail-
able, we used missing genotype calls for SNP rs4607209
in the CNP-10Mb CNP as a surrogate for the deletion
polymorphism (justification in Methods). With the miss-
ing genotype indicator as a surrogate for homozygous
deletions, we fit a mixed effects model implemented in
the R package kinship [31] with log uric acid concen-
trations as the dependent variable and clinical covariates
age, gender, and log-transformed BMI as explanatory vari-
ables. The gender-specific slopes for the surrogate copy
number variable in FHS are comparable to the copy num-
ber slopes in ARIC with respect to magnitude, direction,
and statistical significance (Figure 3). In particular, miss-
ing genotypes are associated with a 1.414.707.88 percentage
increase of uric acid concentrations among FHS women
(p = 5.46 × 10−03) compared to a 3.974.935.87 percent-
age increase among ARIC women (p = 4.57 × 10−23). As
in ARIC, the −3.120.173.36 percentage change in uric acid
concentrations among men is small and not statistically
significant in FHS (p = 0.92). Replication at the CNP-
9Mb CNP is not possible as the array platform used in
FHS does not contain markers in this region.
To investigate whether the association between copy
number and uric acid concentrations is present in non-
EA populations, we estimated the copy number at
both chromosome 4 CNPs for 3,392 African American
(AA) participants in ARIC using the Bayesian mixture
model described previously for the EA cohort. Homozy-
gous deletions occur in approximately 46 and 6% of
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Figure 2 The relationship between integer copy number (x-axis) and average log uric acid concentrations is approximately linear. Slopes
for the copy number coefficients at the chromosome 4 CNP-9Mb (top) and CNP-10Mb (bottom) loci overlay the empirical average log uric acid
concentration with error bars drown to ± two standard errors of the mean. The opposite signs of the regression slopes at CNP-9Mb and CNP-10Mb
is a reflection of linkage disequilibrium – the copy number estimates have a strong, negative correlation (Spearman correlation = -0.82).
EA participants at the CNP-9Mb and CNP-10Mb loci,
respectively, but only 33 and 0.6% of AA participants
have homozygous deletions at these loci. The percentage
decrease of uric acid concentrations associated with each
deleted copy at CNP-9Mb is −0.750.732.22 among women
(p = 0.335) and −1.900.051.97 among men (p = 0.957).
Similarly, copy number is not associated with uric acid
levels among AA women or men at CNP-10Mb (χ22df =
3.45, p = 0.179) (Figure 3).
To assess whether the CNP associations are indepen-
dent of SLC2A9 SNPs among EA participants, we eval-
uated a series of models for uric acid concentrations
that include SNPs and/or the gender-specific CNP slopes.
Marginally, the association between SNPs and CNPs with
uric acid concentrations is the strongest for SNPs directly
in the SLC2A9 transcript, and the associations 200 kb
upstream of SLC2A9 are comparable for SNPs and CNPs
(Figure 4, top). Adjusting for the SNP with the strongest
marginal association (rs7675964), effect sizes for other
SNPs near SLC2A9 decrease. The CNP effect sizes are
also attenuated but remain genome-wide significant (min-
imum χ22 df = 3190, p = 7.23× 10−08) (Figure 4, bottom).
Adjusted for the CNP with the strongest marginal asso-
ciation (CNP-9Mb), the effect size for SNP rs7675964 is
comparable to the marginal model (data not shown).
While regression coefficients for SNPs near SLC2A9
are attenuated in the rs7675964-adjusted models, SNP
rs6449213 (and others) remain genome-wide significant
(p = 9.46×10−11). To assess the independence of the CNP
association with uric acid after adjusting for the rs6449213
and rs7675964 genotypes, we compared the baseline
mixed effects model with rs6449213 and rs7675964 geno-
types to an extended model with gender-specific slopes
for copy number. A 2 degree of freedom likelihood ratio
test comparing the baseline and extended models is sta-
tistically significant at both CNP loci (CNP-9Mb:χ22 df =
31, p = 2.01 × 10−07; CNP-10Mb: χ22 df = 33, p = 8.72 ×
10−08). To further evaluate whether CNPs contribute to
inter-individual variation of uric acid concentrations inde-
pendently of SNPs in SLC2A9, we phased the genotypes at
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Figure 3 Regression coefficients for copy number at the CNP-9Mb and CNP-10Mb loci in ARIC and FHS cohorts. Combined estimates were
obtained by a weighted average using the inverse variance of the model coefficients as weights. Data is not available at the CNP-9Mb loci in FHS
due to the older array technology. ∗Missing genotypes at SNP rs4607209 in the CNP-10Mb locus are modeled as a surrogate for deletion genotypes
in FHS.
rs7675964 and rs6449213 with copy number at CNP-9Mb
and CNP-10Mb (see Methods). Notationally, we denote
the CNP portion of the haplotypes by H1: − −c1,1 − −c1,2 − −H2: − −c2,1 − −c2,2 − − ,
where ci,j is the copy number at the jth CNP locus (ci,j ∈
{0, 1}) for haplotype Hi (i ∈ {1, 2}). Similarly, the por-
tion of the haplotypes for rs7675964 and rs6449213 are
denoted by H1: − −g1,1 − −g1,2 − −H2: − −g2,1 − −g2,2 − − , where gi,j is the allele at
the jth SNP (gi,j ∈ {a, b}). Of the 24 possible allelic hap-
lotypes, 14 were observed in the 8,411 EA participants
and only 3 SNP haplotypes had variation in the corre-
sponding CNP haplotype. Specifically, the 3 SNP haplo-
types for we observed variation in the phased copy num-
ber estimates are H1: − −a − −a − −H2: − −a − −a − − ,
H1: − −b − −b − −
H2: − −a − −a − − , and
H1: − −b − −a − −
H2: − −a − −a − − . For 2,195 subjects with the allelic hap-
lotype H1: − −b − −b − −H2: − −a − −a − − , CNP haplotypes
H1: − −0 − −1 − −
H2: − −1 − −0 − −
and H1: − −0 − −1 − −H2: − −1 − −1 − − are weakly associated with uric
acid concentrations with similar effect sizes observed
in men and women (χ24df = 9.05, p = 0.0599). For
4,313 H1: − −a − −a − −H2: − −a − −a − − subjects, CNP haplotypes are asso-
ciated with uric acid concentrations in women (χ24df =
14.3, p = 6.3 × 10−03) but not men (χ24df = 0.757, p =
0.944). CNP haplotypes are not associated with uric acid
concentrations for H1: − −b − −a − −H2: − −a − −a − − subjects (χ
2
2df =
2.06, p = 0.357), though the sample size for this popula-
tion is small and the effect size among the 66 women in
this subgroup is comparable to the effect size in the much
larger H1: − −b − −b − −H2: − −a − −a − − and
H1: − −a − −a − −
H2: − −a − −a − − subgroups
for which the CNP haplotype association is statistically
significant (Figure 5).
As the CNP association appears independent of SLC2A9
SNPs and the CNP loci are located in an intergenic
region approximately 200 kb upstream of the SLC2A9
gene (SLC2A9 is transcribed in the reverse orientation),
we examined publicly available regulatory data for human
kidney tissue where SLC2A9 is known to function in the
Scharpf et al. BMC Genetics 2014, 15:81 Page 6 of 13
http://www.biomedcentral.com/1471-2156/15/81
Figure 4 SNP and CNP associations near SLC2A9with and without adjustment for genome-wide significant SNP rs7675964. Top: Negative
log10 p-values derived from a likelihood ratio test comparing a null model with clinical and technical covariates to an extended model evaluating
the marginal association of SNPs (gray circles) or CNP × gender (black rectangles). The region shaded in light gray is the location of the SLC2A9
gene. Bottom: Negative log10 p-values from a likelihood ratio test comparing an extended model with SNPs or CNP × gender to a null model that
includes the rs7675964 genotypes.
transport of uric acid from urine to blood [32]. Exami-
nation of DNAse hypersensitivity for human fetal kidney
tissue and adult kidney cell line HKC8 revealed a peak
adjacent to CNP-10Mb, suggesting that CNP-10Mb abuts
a regulatory element. We did not observe DNAse hyper-
sensitivity peaks near CNP-9Mb, but nearly half of EA
participants have a homozygous deletion at CNP-9Mb.
It is unclear whether the absence of peaks at CNP-9Mb
reflect the absence of a regulatory element in the fetal kid-
ney or whether the fetal kidney has a deletion at this locus
(i.e., loss of a regulatory element by deletion).
Given the strong association between CNPs and uric
acid, we modeled the relationship between CNPs and
gout. Of the 8,411 ARIC EA participants, 609 had gout
at some point during the study’s follow-up. In a logistic
regression model including technical and clinical covari-
ates described previously, the odds of gout is 1.21 times
higher comparing subjects who differ by one copy of CNP-
9Mb (p = 0.003). As expected, this association is largely
mediated through the CNP’s association with serum uric
acid. After including uric acid in the model, the asso-
ciation between copy number at CNP-9Mb and gout is
attenuated (1.11 odds ratio; p=0.12). Results are qualita-
tively similar at the CNP-10Mb locus with a statistically
significant gout association in the marginal model that
is attenuated after adjusting for uric acid concentrations
(data not shown).
Conclusions
This study is the first genome-wide scan of CNPs and
uric acid.We identified an association between serum uric
acid concentrations and two common, intergenic dele-
tions that are 200 kb and 350 kb, respectively, upstream
of the urate transporter SLC2A9. Loss of DNA copy
number in these regions is associated with ≈ 5 per-
cent change of uric acid concentrations among women
and a one percent change among men with the direc-
tion of the effect depending on the CNP locus (χ22 df =
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Figure 5 The association of CNP haplotypes with uric acid levels is independent of genome-wide significant SNPs. Genotypes at rs7675964
and rs6449213 were phased with CNP-9Mb and CNP-10Mb. Subjects were stratified into three allelic haplotypes (column labels) for which there
was variation in the CNP haplotypes (y-axis labels). The pair of CNP haplotypes given by H1:−−0−−1−−H2:−−0−−1−− is the reference group for each regression.
Likelihood ratio tests for the CNP haplotypes are statistically significant for women with allelic haplotypes H1:−−a−−a−−H2:−−a−−a−− (χ
2
4df = 14.3, p = 6.3×10−03)
and marginally significant for both men and women with allelic haplotypes H1:−−b−−b−−H2:−−a−−a−− (χ
2
4df = 9.05, p = 0.0599). CNP haplotypes are not
associated with uric acid concentrations among H1:−−b−−a−−H2:−−a−−a−− subjects (χ
2
2df = 2.06, p = 0.357), though the sample size for this cohort is small and
the effect size among the 66 women is comparable to the effect size in the much larger H1:−−b−−b−−H2:−−a−−a−− and
H1:−−a−−a−−
H2:−−a−−a−− subgroups.
3545, p = 3.19 × 10−23). Gender-specific associations
between SLC2A9 polymorphisms and uric acid concen-
trations have been reported by others and are consistent
with our observations with CNPs near SLC2A9 [7,33-36].
Independent replication of the association between copy
number and uric acid concentrations in FHS provides
further support for our finding. Among ARIC AA par-
ticipants, CNP-10Mb is weakly associated with uric acid
concentrations and there was no association at CNP-9Mb
in men or women. The CNP association in ARIC EA is
independent of previously reported SNP associations in
SLC2A9, as assessed by joint CNP and SNP regression
models as well as regression models with phased SNP and
CNP haplotypes.
The physiological role of SLC2A9 in the kidney is the
reabsorption of urate from urine into blood, leading to
increased levels of serum uric acid concentrations when
SLC2A9 expression is up-regulated and decreased levels
with loss of function mutations such as deletions. When
phased with genome-wide significant SNPs in SLC2A9,
the haplotypes with homozygous deletions at CNP-9Mb
had lower uric acid concentrations as we would hypothe-
size if CNP-9Mb spans an enhancer for SLC2A9. DNAse
hypersensitivity assays suggest that CNP-10Mb abuts a
regulatory element, but we did not find DNAse hypersen-
sitivity or ChiP-seq peaks at CNP-9Mb. Assays from other
cell lines in ENCODE are consistent with our findings in
the kidney. For example, CNP-10Mb spans DNAse hyper-
sensitivity peaks in normal esophageal epithelial cells
(HEEpiC cell line), airway epithelial cells (SAEC cell line),
epidermal keratinocytes (cell line NHEK), and mammary
epithelial cells (HMEC cell line), as well as a H3KMe1
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histone mark in HMEC cells [37]. As nearly 50 percent
of EA participants in ARIC have homozygous deletions
at CNP-9Mb, it is possible that the fetal kidney cell line
harbors a homozygous deletion at this locus and that the
absence of ChiP-seq binding and DNAse hypersensitivity
reflect absence of regulatory elements due to loss of DNA
copy number. Gene expression data for kidney or liver tis-
sues and germline copy number for the same samples is
not currently available in ARIC or FHS.
Our CNP GWAS has low sensitivity for deletions less
than 50 kb in size and/or having fewer than 10 Affymetrix
6.0 markers. For amplifications, the inability to discrimi-
nate high copy amplifications from single- and two- copy
duplications because of the limited dynamic range of the
array platform will attenuate the regression coefficients
for copy number. The attenuation of the copy number
coefficients for amplifications occurs irrespective of the
size of the amplicon, but will be worse for small, focal
amplifications due to the limited resolution of the plat-
form. Our analyses do not rule out the contribution of
small insertions and deletions as well as high copy repeats
that are beyond the dynamic range of high-throughput
arrays. Sequencing platforms will be useful for elucidat-
ing whether additional structural and mutational variants
near SLC2A9 contribute to inter-individual heterogeneity
of uric acid concentrations. In addition, our association
analysis only included CNPs. Rare duplications and dele-
tions such as those directly spanning the SLC2A9 tran-
script (5 deletions and 9 duplications in ARIC) were not
evaluated in our analysis of CNPs and may have a larger
effect on uric acid concentrations than the CNPs stud-
ied here. While these limitations impact sensitivity, our
results indicate that CNP genome-wide association stud-
ies can achieve a high degree of specificity. As in any
high-throughput setting, the specificity of a genome-wide
screen depends on the extent to which technical factors
influencing estimation can be modeled and the degree to
which they are independent of the outcome of interest.
Participants in ARIC were neither enrolled nor processed
on the basis of their uric acid concentrations. Due to the
merits of the experimental design and mixed models for
uric acid that adjust for study center and chemistry plate,
we feel the major sources of artefactual associations in
ARIC have been addressed.
In summary, the loss of several kilobases of DNA in
close proximity to SLC2A9, a known uric acid transporter
and a candidate gene for gout [38-40], presents a bio-
logically plausible mechanism for regulation of SLC2A9
expression and modulation of serum uric acid concentra-
tions. Gene expression data on the same set of individuals
in target kidney and liver tissues is needed to evaluate
whether loss of DNA copy number effects transcription
of SLC2A9 as hypothesized, and to evaluate gender differ-
ences in SLC2A9 expression.
Methods
This paper follows the guidelines for communicating con-
fidence intervals as suggested in [41]. Institutional Review
Board (IRB) approval was obtained by the Johns Hopkins
University ARIC study center, and the research was con-
ducted in accordance with the principles described in the
Declaration of Helsinki.
ARIC study
The ARIC study is an ongoing, prospective community-
based cohort of 15,792 persons (27% black) aged
45-64 years at baseline (1987-89) [42]. Participants
were selected by probability sampling from four U.S.
communities (Forsyth County, North Carolina; Jackson,
Mississippi; Minneapolis, Minnesota; and Washington
County, Maryland). Participants took part in examina-
tions starting with a baseline visit between 1987 and 1989
and three follow-up visits, thereafter, administered three
years apart (visit 2: 1990-1992; visit 3: 1993-1995; visit 4:
1996-1998). At baseline, a home interview assessed par-
ticipants’ sociodemographic characteristics, smoking, and
alcohol-drinking habits, medication use, and medical his-
tory. A clinical examination included measurement of
various risk factors. All participants self-reported race as
Asian, black, American Indian, or white. Body-mass index
(BMI) was measured according to published methods
[43]. Central laboratories performed analyses on baseline
fasting specimens using conventional assays to obtain uric
acid values [44]. Uric acid was measured by the uricase
method [45]. The reliability coefficient of uric acid was
0.91, and within-person variability was 7.2 [46].
CNV estimation
Raw CEL files from scanned Affymetrix 6.0 arrays were
processed using Affymetrix power tools (APT, version
1.14.3) and PennCNV to derive estimates of log R ratios
and B allele frequencies at each marker. While the log R
ratio estimates were wave-adjusted [21], genomic waves
persisted in many of the ARIC samples. We further pro-
cessed the log R ratios using the R package ArrayTV
[47] – an approach adapted from software for remov-
ing waves in high-throughput sequencing data [48]. A
6-state HMM comprising 5 distinct copy number states
(0-4) implemented in the R package VanillaICE (VI) and
the stand-alone tool PennCNV were applied indepen-
dently to each sample [13,14,49]. CNVs with fewer than
10 markers were excluded due to the level of noise of the
log R ratios and the difficulty in assessing the validity of
low-coverage CNVs without experimental validation. As
inference from association models using the PennCNV-
and VI- derived copy number estimates were found to be
qualitatively similar, only theVI copy number associations
were reported.
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Quality control measures
Among 9,779 samples of EA for whom uric acid concen-
trations weremeasured at visit 1, we excluded 743 samples
that did not meet criteria for SNP genome-wide asso-
ciation analyses in ARIC as described in Köttgen et al.
[50]. For the estimation of germline CNVs, high CNV
call frequencies often indicate problems with the normal-
ization such as genomic waves that were incompletely
removed by the wave correction methods. We excluded
625 participants with autosomal log R ratios having high
autocorrelation or variance (lag 10 autocorrelation > 0.03
or median absolute deviation > 0.32), or if the num-
ber of CNVs called by the VI algorithm exceeded 100.
We used the signal to noise ratio (SNR) implemented
in the R package crlmm as a sample-specific measure
of array quality as assessed by the overall separation of
the canonical genotype clusters at SNPs [51,52], but we
did not exclude samples on the basis of this statistic.
Following the above quality control filters, 8,411 EA par-
ticipants were evaluated in the subsequent association
models.
Genome-wide scan of copy number and uric acid levels
From the set of genomic intervals defining CNVs derived
by the VI HMM fit to 8,411 EA subjects, we constructed
rectangular matrices of the inferred integer copy num-
ber. Element [ i, j] of the matrix is the copy number
at genomic interval i for sample j. The genomic inter-
vals were obtained from the union of the start and end
coordinates across all CNVs detected for each of the
autosomal chromosomes with the requirement that each
non-overlapping (disjoint) interval contain at least one
marker. For each disjoint interval, we calculated the num-
ber of samples harboring a CNV, excluding intervals
for which fewer than one percent of the samples had
a CNV. Across samples, the CNVs are partially over-
lapping and any given CNV may span one or many
disjoint intervals. As a consequence, adjacent disjoint
intervals often convey similar information with compa-
rable frequencies of deletions and duplications. As the
test statistics are correlated, Bonferonni correction is
conservative. Because none of the loci were of border-
line statistical significance (Additional file 1: Figure S3),
more sophisticated simulation-based approaches for
multiple testing correction with dependent test statistics
were not assessed.
Mixed effects regression models for ARIC cohorts were
implemented using the R package lme4 [53]. Specifically, we
modeled seasonally adjusted serum log uric acid concen-
trations (continuous) in a regression model with fixed
effects for copy number (modeled as continuous with scale
0-4), age (continuous), log-transformed BMI (continuous),
gender, and study center (categorical). As the heavy-tailed
uric acid concentrations were log-transformed, we report
the percentage change of uric acid concentrations per
integer increase in copy number. To take into account
the heterogeneity of CNV call frequencies between chem-
istry plates, we include chemistry plate as a random
effect. For regression models with canonical genotypes as
covariates, we treated the frequency of the B-allele (an
integer in the set 0, 1, or 2) as continuous. For FHS,
we implemented mixed effects regression models using the
R package kinship (http://cran.uvigo.es/src/
contrib/Archive/kinship/) [31].
Imputation of copy number in the Framingham heart study
To evaluate whether CNPs at the chromosome 4 loci are
associated with uric acid in an independently sampled EA
population, we explored replication in FHS. Challenges
to replication in FHS include the older array architecture
(Affymetrix 250k Nsp/Sty chips) and the unavailability
of raw intensities needed for copy number estimation.
While there were no markers for CNP-9Mb on the 250k
chips, SNP rs4607209 in CNP-10Mb is present in the
Affymetrix 250k Nsp chip. To verify that the expected
non-diploid genotypes (‘A’, ‘B’, and NULL genotypes) can
be observed from the normalized intensities for this SNP
on the Affymetrix 250k Nsp chip, we genotyped the 270
phase 2 HapMap samples that were assayed on the the
Affymetrix 250k platform using the BRLMM algorithm
implemented in Affymetrix power tools. (The BRLMM
algorithm was used to genotype FHS participants.) A
scatterplot of the log intensities for the A and B alle-
les reveals three clusters corresponding to the deletion
genotypes for rs4607209 in addition to the canonical bial-
lelic clusters (Additional file 1: Figure S5), and is similar
to the clusters observed on the Affymetrix 6.0 platform
for ARIC EA participants (Figure 1D). Homozygous dele-
tions occur in 8.9% of the HapMap CEPH samples and
6.1% of the ARIC EA participants. The canonical bial-
lelic genotypes in HapMap have high genotype confidence
scores (not shown) and no missing calls, while 6 out of 8
CEPH subjects with homozygous deletions have missing
BRLMM genotype calls. These data demonstrate that the
low level intensities for SNP rs4607209 in both the 250k
Nsp and Affymetrix 6.0 platforms have distinct clusters
corresponding to the latent copy number and that missing
BRLMM genotypes occur in clusters that are consistent
with homozygous deletions. The specificity of missing
genotype calls as a surrogate for homozygous deletion
genotypes at SNP rs4607209 in EA HapMap is 1 and
the sensitivity is 0.75. We expect that missing genotype
calls as a surrogate for homozygous deletions will lead
to conservative parameter estimates of the copy number
effect size in regression models as contamination of the
diploid population with subjects harboring homozygous
and hemizygous deletions will bias the regression slopes
to zero.
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Estimation of copy number for ARIC AA participants
Log R ratios for markers in the CNP-9Mb and CNP-
10Mb loci were averaged. The average log R ratios in AA
participants are a mixture of 3 normal distributions as
observed in the EA population, with the mixture compo-
nents presumed to be induced by differences in the latent
copy number. A Gibbs’ sampler [27,28] was implemented
in R to approximate the posterior distribution of the 3-
component normal mixture. Each subject was assigned
to the mixture component with the highest posterior
probability. As in the EA cohort, the observed mixture
components in the AA cohort are most consistent with
homozygous deletion, hemizygous deletion, and diploid
copy number on the basis of the expected log R ratios for
these copy number states.
Phasing SNPs and CNPs near SLC2A9
Genotypes from 8 SNPs having the largest marginal
associations with uric acid (including rs7675964 and
rs6449213) were phased with CNP-9Mb and CNP-10Mb
using the fastPHASE software [54]. For diploid CNPs, we
assumed that each haplotype had one copy. This assump-
tion is supported empirically by the data–if haplotypes
containing two copies were common, we would expect
to see subjects with duplications. Haplotypes were mod-
eled as categorical covariates in regression models for uric
acid concentrations. Subjects with rare haplotypes and
subjects with allelic haplotypes that had no variation in
the corresponding CNP portion of the haplotypes were
excluded (1,473 subjects).
Genomic annotation and software versions
Genomic annotation in this paper is based on UCSC build
hg18 (NCBI36) [55]. Gene SLC2A9 has RefSeq accession
numbers NM_001001290.1 and NM_020041.2. We used
the May, 2010 version of PennCNV, version 1.14.3 of
APT, and version 1.4.0 of fastPHASE [54]. All remaining
analyses were performed in the statistical environment R
[56]. Graphics were generated using the R packages lat-
tice [57] or ggbio [58,59]. The analyses downstream of
the VI algorithm relied on the infrastructure provided by
the GenomicRanges package [60]. The complete listing of
supporting R packages and their corresponding version
numbers is provided below.
• R version 3.1.0 (2014-04-10),
x86_64-apple-darwin13.1.0
• Base packages: base, datasets, graphics, grDevices,
grid, methods, parallel, stats, tools, utils
• Other packages: aricUricAcid 1.0.19, Biobase 2.24.0,
BiocGenerics 0.10.0, Biostrings 2.32.0, DBI 0.2-7,
devtools 1.5, foreach 1.4.2, GenomeInfoDb 1.0.2,
GenomicRanges 1.16.3, ggplot2 1.0.0, gridExtra 0.9.1,
gtable 0.1.2, IRanges 1.22.7, knitr 1.6, lattice 0.20-29,
lme4 1.1-6, Matrix 1.1-3, oligo 1.28.2,
oligoClasses 1.26.0, pd.genomewidesnp.6 1.10.0,
RColorBrewer 1.0-5, Rcpp 0.11.1, RSQLite 0.11.4,
XVector 0.4.0
• Loaded via a namespace (and not attached):
affxparser 1.36.0, affyio 1.32.0, BiocInstaller 1.14.2,
bit 1.1-12, codetools 0.2-8, colorspace 1.2-4,
digest 0.6.4, evaluate 0.5.5, ff 2.2-13, formatR 0.10,
gtools 3.4.0, httr 0.3, iterators 1.0.7,
latticeExtra 0.6-26, MASS 7.3-33, memoise 0.2.1,
minqa 1.2.3, munsell 0.4.2, nlme 3.1-117, plyr 1.8.1,
preprocessCore 1.26.1, proto 0.3-10,
RcppEigen 0.3.2.1.2, RCurl 1.95-4.1, reshape2 1.4,
scales 0.2.4, splines 3.1.0, stats4 3.1.0, stringr 0.6.2,
whisker 0.3-2, zlibbioc 1.10.0
Availability of supporting data
The data set supporting the results of this article is
available in the dbGaP repository, phs000090.v1.p1
(http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.
cgi?study_id=phs000090.v1.p1). The ChiP-seq and DNAase
hypersensitivity data for the kidney described in




Additional file 1: Supplementary figures and tables. Figure S1: Size,
frequency and burden of CNVs among ARIC participants of European
ancestry. Figure S2: Batch effects in processing arrays for copy number
estimation. Figure S3:Manhattan plot of copy number associations.
Figure S4: Quantile-quantile plot of the expected − log10 p-values versus
the observed − log10 p-values. Figure S5: A scatterplot of the normalized
intensities for the A and B alleles of SNP rs4607209 for 90 HapMap subjects
of EA assayed on the Affymetrix 250k Nsp chip used in FHS. Table S1:
Median and interquartile range (IQR) descriptive statistics of CNVs for 8,411
EA participants.
Abbreviations
AA: African American; ARIC: Atherosclerosis risk in communities; BMI: Body
mass index; ChiP: Chromatin immunoprecipitation; CNP: Copy number variant;
CNP: Copy number polymorphism; EA: European ancestry; FHS: Framingham
heart study; HMM: Hidden Markov model; MAD: Median absolute deviation;
SNP: Single nucleotide polymorphism; SNR: Signal to noise ratio.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RBS, JC, and WKHL conceived of the study. RBS, LM, AK, EB, CSF, AC, KS, and
WKHL drafted the manuscript. KS and AK participated in the analysis and
interpretation of DNAse hypersensitivity and ChIP-seq assays. RBS, LM, EHS, QY,
IR, AT, and SC participated in the statistical analyses. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported by National Institutes of Health grants R01HG005220
and R00HG005015 [R.B.S., L.M., A.C., W.H.L.K.]. The Atherosclerosis Risk in
Communities Study is carried out as a collaborative study supported by
National Heart, Lung, and Blood Institute contracts (HHSN268201100005C,
Scharpf et al. BMC Genetics 2014, 15:81 Page 11 of 13
http://www.biomedcentral.com/1471-2156/15/81
HHSN268201100006C, HHSN268201100007C, HHSN268201100008C,
HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and
HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694;
National Human Genome Research Institute contract U01HG004402; and
National Institutes of Health contract HHSN268200625226C. The research was
conducted in part using data and resources from the Framingham Heart Study
of the National Heart Lung and Blood Institute of the National Institutes of
Health and Boston University School of Medicine (Contract No.
N01-HC-25195), its contract with Affymetrix, Inc for genotyping services
(Contract No. N02-HL-6-4278) and National Institute of Health grants R01
NS017950-28 and R01-HL093328-01. The analyses reflect intellectual input and
resource development from the Framingham Heart Study investigators
participating in the SNP Health Association Resource (SHARe) project.
Framingham Heart Study investigators were supported in part by the National
Heart, Lung, and Blood Institute’s Framingham Heart Study (Contract No.
N01-HC-25195) and grant numbers R01HL093328, R01HL093029,
R01NS017950 and R01HL093029 [C.F.S. and Q.Y.]. The funders had no role in
study design, data collection and analysis, decision to publish, or preparation
of the manuscript. The authors thank the staff and participants of the ARIC and
FHS studies for their important contributions. We thank Dan Arking for the
suggestion of phasing the SNP and CNP haplotypes.
Author details
1550 N. Broadway, Suite 1101, Department of Oncology, Johns Hopkins School
of Medicine, Baltimore, Maryland 21205, USA. 2Department of Epidemiology,
Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
3Department of Biostatistics, Boston University School of Public Health,
Boston, Massachusetts, USA. 4Department of Medicine IV, University Hospital
Freiburg, Freiburg im Breisgau, Germany. 5Department of Biostatistics, Johns
Hopkins School of Public Health, Baltimore, Maryland, USA. 6Renal Electrolyte
and Hypertension Division, Perelman School of Medicine, University of
Pennsylvania, Philadelphia PA, USA. 7Computational Biosciences Program,
University of Colorado, Denver, Aurora, Colorado, USA. 8Department of
Biostatistics, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
9Department of Medicine, Johns Hopkins School of Medicine, Baltimore,
Maryland, USA. 10IMM Center for Human Genetics, University of Texas School
of Public Health, Houston, Texas, USA. 11Laboratory for Metabolic and
Population Health, National Heart Lung and Blood Institute, National Institutes
of Health, Framingham, Massachusetts, USA.
Received: 31 March 2014 Accepted: 30 June 2014
Published: 9 July 2014
References
1. Liese AD, Hense HW, Löwel H, Döring A, Tietze M, Keil U: Association of
serum uric acid with all-cause and cardiovascular disease mortality
and incident myocardial infarction in the MONICA Augsburg cohort.
World Health Organization monitoring trends and determinants in
cardiovascular diseases. Epidemiology 1999, 10(4):391–397.
2. Feig DI, Kang D-H, Johnson RJ: Uric acid and cardiovascular risk. N Engl
J Med 2008, 359(17):1811–1821. doi:10.1056/NEJMra0800885.
3. Rao DC, Laskarzewski PM, Morrison JA, Khoury P, Kelly K, Glueck CJ: The
clinical lipid research clinic family study: familial determinants of
plasma uric acid. HumGenet 1982, 60(3):257–261.
4. Rice T, Vogler GP, Perry TS, Laskarzewski PM, Province MA, Rao DC:
Heterogeneity in the familial aggregation of fasting serum uric acid
level in five North American populations: the lipid research clinics
family study. Am JMed Genet 1990, 36(2):219–225.
doi:10.1002/ajmg.1320360216.
5. Charles BA, Shriner D, Doumatey A, Chen G, Zhou J, Huang H, Herbert A,
Gerry NP, Christman MF, Adeyemo A, Rotimi CN: A genome-wide
association study of serum uric acid in African Americans. BMCMed
Genomics 2011, 4:17. doi:10.1186/1755-8794-4-17.
6. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, Ahmadi K,
Dobson RJ, Marécano ACB, Hajat C, Burton P, Deloukas P, Brown M,
Connell JM, Dominiczak A, Lathrop GM, Webster J, Farrall M, Spector T,
Samani NJ, Caulfield MJ, Munroe PB: Genome-wide association study
identifies genes for biomarkers of cardiovascular disease: serum
urate and dyslipidemia. Am J HumGenet 2008, 82(1):139–149.
doi:10.1016/j.ajhg.2007.11.001.
7. Dehghan A, Köttgen A, Yang Q, Hwang S-J, Kao WL, Rivadeneira F,
Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM,
Witteman JC, Coresh J, Fox CS: Association of three genetic loci with
uric acid concentration and risk of gout: a genome-wide association
study. Lancet 2008, 372(9654):1953–1961.
doi:10.1016/S0140-6736(08)61343-4.
8. Karns R, Zhang G, Sun G, Rao Indugula S, Cheng H, Havas-Augustin D,
Novokmet N, Rudan D, Durakovic Z, Missoni S, Chakraborty R, Rudan P,
Deka R: Genome-wide association of serum uric acid concentration:
replication of sequence variants in an island population of the
Adriatic coast of Croatia. Ann HumGenet 2012, 76(2):121–127.
doi:10.1111/j.1469-1809.2011.00698.x.
9. Tin A, Woodward OM, Kao WHL, Liu C-T, Lu X, Nalls MA, Shriner D,
Semmo M, Akylbekova EL, Wyatt SB, Hwang S-J, Yang Q, Zonderman AB,
Adeyemo AA, Palmer C, Meng Y, Reilly M, Shlipak MG, Siscovick D,
Evans MK, Rotimi CN, Flessner MF, Köttgen M, Cupples LA, Fox CS,
Köttgen A, Candidate Gene Associated Resource (C. A. Re), Cohorts for
Heart and Aging Research in Genetic Epidemiology (C. H. A. R. G. E.):
Genome-wide association study for serum urate concentrations and
gout among African Americans identifies genomic risk loci and a
novel URAT1 loss-of-function allele. HumMol Genet 2011,
20(20):4056–4068.
10. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, Mangino M,
Albrecht E, Wallace C, Farrall M, Johansson A, Nyholt DR, Aulchenko Y,
Beckmann JS, Bergmann S, Bochud M, Brown M, Campbell H, European
Special Population Research Network (EUROSPAN), Connell J,
Dominiczak A, Homuth G, Lamina C, McCarthy MI, European Network for
Genetic and Genomic Epidemiology (ENGAGE), Meitinger T, Mooser V,
Munroe P, Nauck M, Peden J, et al:Meta-analysis of 28,141 individuals
identifies common variants within five new loci that influence uric
acid concentrations. PLoS Genet 2009, 5(6):1000504.
doi:10.1371/journal.pgen.1000504.
11. Peiffer DA, Le JM, Steemers FJ, Chang W, Jenniges T, Garcia F, Haden K,
Li J, Shaw CA, Belmont J, Cheung SW, Shen RM, Barker DL, Gunderson KL:
High-resolution genomic profiling of chromosomal aberrations
using Infiniumwhole-genome genotyping. Genome Res 2006,
16(9):1136–1148. doi:10.1101/gr.5402306.
12. Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P, Bassett AS, Seller
A, Holmes CC, Ragoussis J: QuantiSNP: an Objective Bayes
Hidden-Markov Model to detect and accurately map copy number
variation using SNP genotyping data. Nucleic Acids Res 2007,
35(6):2013–2025. doi:10.1093/nar/gkm076.
13. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SFA, Hakonarson H, Bucan
M: PennCNV: an integrated hidden Markov model designed for
high-resolution copy number variation detection in whole-genome
SNP genotyping data. Genome Res 2007, 17(11):1665–1674.
doi:10.1101/gr.6861907.
14. Scharpf RB, Parmigiani G, Pevsner J, Ruczinski I: Hidden Markov models
for the assessment of chromosomal alterations using
high-throughput SNP arrays. Ann Appl Stat 2008, 2(2):687–713.
15. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S,
Hubbell E, Veitch J, Collins PJ, Darvishi K, Lee C, Nizzari MM, Gabriel SB,
Purcell S, Daly MJ, Altshuler D: Integrated genotype calling and
association analysis of SNPs, common copy number polymorphisms
and rare CNVs. Nat Genet 2008, 40(10):1253–1260. doi:10.1038/ng.237.
16. Greenman CD, Bignell G, Butler A, Edkins S, Hinton J, Beare D, Swamy S,
Santarius T, Chen L, Widaa S, Futreal PA, Stratton MR: PICNIC: an
algorithm to predict absolute allelic copy number variation with
microarray cancer data. Biostatistics 2010, 11(1):164–175.
doi:10.1093/biostatistics/kxp045.
17. Su S-Y, Asher JE, Jarvelin M-R, Froguel P, Blakemore AIF, Balding DJ, Coin
LJM: Inferring combined CNV/SNP haplotypes from genotype data.
Bioinformatics 2010, 26(11):1437–1445.
doi:10.1093/bioinformatics/btq157.
18. Yau C, Mouradov D, Jorissen RN, Colella S, Mirza G, Steers G, Harris A,
Ragoussis J, Sieber O, Holmes CC: A statistical approach for detecting
genomic aberrations in heterogeneous tumor samples from single
nucleotide polymorphism genotyping data. Genome Biol 2010,
11(9):92. doi:10.1186/gb-2010-11-9-r92.
19. Yau C, Papaspiliopoulos O, Roberts GO, Holmes C: Bayesian
nonparametric hidden Markov models with application to the
Scharpf et al. BMC Genetics 2014, 15:81 Page 12 of 13
http://www.biomedcentral.com/1471-2156/15/81
analysis of copy number variation in mammalian genomes. J R Stat
Soc Series B Stat Methodol 2011, 73(1):37–57.
doi:10.1111/j.1467-9868.2010.00756.x.
20. Marioni JC, Thorne NP, Valsesia A, Fitzgerald T, Redon R, Fiegler H, Andrews
TD, Stranger BE, Lynch AG, Dermitzakis ET, Carter NP, Tavaré S, Hurles ME:
Breaking the waves: improved detection of copy number variation
frommicroarray-based comparative genomic hybridization.
Genome Biol 2007, 8(10):228. doi:10.1186/gb-2007-8-10-r228.
21. Diskin SJ, Li M, Hou C, Yang S, Glessner J, Hakonarson H, Bucan M, Maris
JM, Wang K: Adjustment of genomic waves in signal intensities from
whole-genome SNP genotyping platforms. Nucleic Acids Res 2008,
36(19):126. doi:10.1093/nar/gkn556.
22. Barnes C, Plagnol V, Fitzgerald T, Redon R, Marchini J, Clayton D, Hurles
ME: A robust statistical method for case-control association testing
with copy number variation. Nat Genet 2008, 40(10):1245–1252.
doi:10.1038/ng.206.
23. Leek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B, Johnson WE,
Geman D, Baggerly K, Irizarry RA: Tackling the widespread and critical
impact of batch effects in high-throughput data. Nat Rev Genet 2010,
11(10):733–739. doi:10.1038/nrg2825.
24. Scharpf RB, Ruczinski I, Carvalho B, Doan B, Chakravarti A, Irizarry RA: A
multilevel model to address batch effects in copy number
estimation using SNP arrays. Biostatistics 2011, 12(1):33–50.
doi:10.1093/biostatistics/kxq043.
25. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW,
Lee C: Detection of large-scale variation in the human genome. Nat
Genet 2004, 36(9):949–951. doi:10.1038/ng1416.
26. McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, Barrett JC,
Dallaire S, Gabriel SB, Lee C, Daly MJ, Altshuler DM, Consortium IH:
Common deletion polymorphisms in the human genome. Nat Genet
2006, 38(1):86–92.
27. Geman S, Geman D: Stochastic relaxation, gibbs distributions, and
the bayesian restoration of images. IEEE Trans Pattern Anal Mach Intell
1984, 6(6):721–741.
28. Diebolt J, Robert CP: Estimation of finitemixture distributions through
Bayesian sampling. J R Stat Soc Series B Methodol 1994, 56:363–375.
29. Cardin N, Holmes C, WTCCC, Donnelly P, Marchini J: Bayesian
hierarchical mixture modeling to assign copy number from a
targeted cnv array. Genet Epidemiol 2011, 35(6):536–548.
doi:10.1002/gepi.20604.
30. McCarroll SA, Kuruvilla FG, Korn JM, Cawley S, Nemesh J, Wysoker A,
Shapero MH, de Bakker PIW, Maller JB, Kirby A, Elliott AL, Parkin M,
Hubbell E, Webster T, Mei R, Veitch J, Collins PJ, Handsaker R, Lincoln S,
Nizzari M, Blume J, Jones KW, Rava R, Daly MJ, Gabriel SB, Altshuler D:
Integrated detection and population-genetic analysis of SNPs and
copy number variation. Nat Genet 2008, 40(10):1166–1174.
doi:10.1038/ng.238.
31. Atkinson B, Therneau T: Kinship: mixed-effects cox models, sparse
matrices, andmodeling data from large pedigrees. 2013. R package
version 1.1.0-23. [http://cran.uvigo.es/src/contrib/Archive/kinship/]
32. Ko Y-A, Mohtat D, Suzuki M, Park ASD, Izquierdo MC, Han SY, Kang HM, Si
H, Hostetter T, Pullman JM, Fazzari M, Verma A, Zheng D, Greally JM,
Susztak K: Cytosine methylation changes in enhancer regions of core
pro-fibrotic genes characterize kidney fibrosis development.
Genome Biol 2013, 14(10):108. doi:10.1186/gb-2013-14-10-r108.
33. Döering A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, Fischer G,
Henke K, Klopp N, Kronenberg F, Paulweber B, Pfeufer A, Rosskopf D,
Völzke H, Illig T, Meitinger T, Wichmann H.-E, Meisinger C: SLC2A9
influences uric acid concentrations with pronounced sex-specific
effects. Nat Genet 2008, 40(4):430–436. doi:10.1038/ng.107.
34. McArdle PF, Parsa A, Chang Y-PC, Weir MR, O’Connell JR, Mitchell BD,
Shuldiner AR: Association of a common nonsynonymous variant in
GLUT9 with serum uric acid levels in old order amish. Arthritis Rheum
2008, 58(9):2874–2881. doi:10.1002/art.23752.
35. Hu M, Tomlinson B: Gender-dependent associations of uric acid levels
with a polymorphism in SLC2A9 in Han Chinese patients. Scand J
Rheumatol 2012, 41(2):161–163. doi:10.3109/030097422011.637952.
36. Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C,
Pistis G, Ruggiero D, O’Seaghdha CM, Haller T, Yang Q, Tanaka T, Johnson
AD, Kutalik Z, Smith AV, Shi J, Struchalin M, Middelberg RPS, Brown MJ,
Gaffo AL, Pirastu N, Li G, Hayward C, Zemunik T, Huffman J, Yengo L, Zhao
JH, Demirkan A, Feitosa MF, Liu X, et al: Genome-wide association
analyses identify 18 new loci associated with serum urate
concentrations. Nat Genet 2013, 45(2):145–154. doi:10.1038/ng.2500.
37. ENCODE Project Consortium, Bernstein BE, Birney E, Dunham I, Green ED,
Gunter C, Snyder M: An integrated encyclopedia of DNA elements in
the human genome. Nature 2012, 489(7414):57–74.
doi:10.1038/nature11247.
38. Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, Lai S, Dei M, Orrù M,
Albai G, Bandinelli S, Schlessinger D, Lakatta E, Scuteri A, Najjar S. S,
Guralnik J, Naitza S, Crisponi L, Cao A, Abecasis G, Ferrucci L, Uda M, Chen
W.-M, Nagaraja R: The GLUT9 gene is associated with serum uric acid
levels in Sardinia and Chianti cohorts. PLoS Genet 2007, 3(11):194.
doi:10.1371/journal.pgen.0030194.
39. Matsuo H, Chiba T, Nagamori S, Nakayama A, Domoto H, Phetdee K,
Wiriyasermkul P, Kikuchi Y, Oda T, Nishiyama J, Nakamura T, Morimoto Y,
Kamakura K, Sakurai Y, Nonoyama S, Kanai Y, Shinomiya N:Mutations in
glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J
HumGenet 2008, 83(6):744–751. doi:10.1016/j.ajhg.2008.11.001.
40. Doblado M, Moley KH: Facilitative glucose transporter 9, a unique
hexose and urate transporter. Am J Physiol Endocrinol Metab 2009,
297(4):831–835. doi:10.1152/ajpendo.00296.2009.
41. Louis TA, Zeger SL: Effective communication of standard errors and
confidence intervals. Biostatistics 2009, 10(1):1–2.
doi:10.1093/biostatistics/kxn014.
42. ARIC investigators: The atherosclerosis risk in communities (aric)
study: design and objectives. The ARIC investigators. Am J Epidemiol
1989, 129(4):687–702.
43. Center ARiCC: Operations Manual No. 2: Cohort Component Procedures.
Chapel Hill: University of North Caroline School of Public Health; 1987.
44. Center ARiCC: Operations Manual No. 10: Clinical Chemistry Determinations.
Chapel Hill: University of North Caroline School of Public Health; 1987.
45. Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ: Correlates of
uric acid and its association with asymptomatic carotid
atherosclerosis: the ARIC study. Atherosclerosis Risk in
Communities. Ann Epidemiol 1996, 6(4):331–340.
46. Eckfeldt JH, Chambless LE, Shen YL: Short-term, within-person
variability in clinical chemistry test results. Experience from the
atherosclerosis risk in communities study. Arch Pathol LabMed 1994,
118(5):496–500.
47. Halper-Stromberg E, Scharpf RB, ArrayTV:Wave Correction for Arrays.
2013. R package version 1.0.0. [http://www.bioconductor.org/packages/
release/bioc/html/ArrayTV.html]
48. Benjamini Y, Speed TP: Summarizing and correcting the GC content
bias in high-throughput sequencing. Nucleic Acids Res 2012, 40(10):72.
doi:10.1093/nar/gks001.
49. Scharpf RB, Beaty TH, Schwender H, Younkin SG, Scott AF, Ruczinski I: Fast
detection of de novo copy number variants from SNP arrays for
case-parent trios. BMC Bioinformatics 2012, 13(1):330.
doi:10.1186/1471-2105-13-330.
50. Köttgen A, Glazer NL, Dehghan A, Hwang S-J, Katz R, Li M, Yang Q,
Gudnason V, Launer LJ, Harris TB, Smith AV, Arking DE, Astor BC,
Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Chen Y-DI, de Boer IH,
Haritunians T, Lumley T, Sarnak M, Siscovick D, Benjamin EJ, Levy D,
Upadhyay A, Aulchenko YS, Hofman A, Rivadeneira F, Uitterlinden AG,
et al.:Multiple loci associated with indices of renal function and
chronic kidney disease. Nat Genet 2009. doi:10.1038/ng.377.
51. Carvalho B, Bengtsson H, Speed TP, Irizarry RA: Exploration,
normalization, and genotype calls of high-density oligonucleotide
SNP array data. Biostatistics 2007, 8(2):485–499.
doi:10.1093/biostatistics/kxl042.
52. Lin S, Carvalho B, Cutler D, Arking D, Chakravarti A, Irizarry R: Validation
and extension of an empirical Bayes method for SNP calling on
Affymetrix microarrays. Genome Biol 2008, 9(4):63.
doi:10.1186/gb-2008-9-4-r63.
53. Bates D, Maechler M, Bolker B: Lme4: Linear mixed-effects models
using S4 classes. 2012. R package version 0.999999-0. [http://CRAN.R-
project.org/package=lme4]
54. Scheet P, Stephens M: A fast and flexible statistical model for
large-scale population genotype data: applications to inferring
missing genotypes and haplotypic phase. Am J HumGenet 2006,
78(4):629–644. doi:10.1086/502802.
Scharpf et al. BMC Genetics 2014, 15:81 Page 13 of 13
http://www.biomedcentral.com/1471-2156/15/81
55. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS,
Goldman M, Barber GP, Clawson H, Coelho A, Diekhans M, Dreszer TR,
Giardine BM, Harte RA, Hillman-Jackson J, Hsu F, Kirkup V, Kuhn RM,
Learned K, Li CH, Meyer LR, Pohl A, Raney BJ, Rosenbloom KR, Smith KE,
Haussler D, Kent WJ: The UCSC genome browser database: update
2011. Nucleic Acids Res 2011, 39(Database issue):876–882.
doi:10.1093/nar/gkq963.
56. R Development Core Team: R: A Language and Environment for Statistical
Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.
[http://www.R-project.org/].
57. Sarkar D: Lattice: Multivariate Data VisualizationWith R. New York: Springer;
2008. ISBN 978-0-387-75968-5.
58. Wickham H: ggplot2: Elegant Graphics for Data Analysis. Use R!. 233 Spring
Street, New York, NY 10013, USA: Springer; 2009.
59. Yin T, Cook D, Lawrence M: ggbio: an R package for extending the
grammar of graphics for genomic data. Genome Biol 2012, 13(8):77.
60. Lawrence M, Huber W, Pages H, Aboyoun P, Carlson M, Gentleman R,
Morgan MT, Carey VJ: Software for computing and annotating
genomic ranges. PLoS Comput Biol 2013, 9(8):1003118.
doi:10.1371/journal.pcbi.1003118.
doi:10.1186/1471-2156-15-81
Cite this article as: Scharpf et al.: Copy number polymorphisms near
SLC2A9 are associated with serum uric acid concentrations. BMC Genetics
2014 15:81.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
